UBS analyst AJ Rice raised the firm’s price target on Pediatrix Medical (MD) to $16.50 from $16 and keeps a Neutral rating on the shares.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MD:
- Pediatrix Medical sees FY25 adjusted EBITDA $245M-$255M
- Pediatrix Medical reports Q2 adjusted EPS 53c, consensus 42c
- Pediatrix Medical Group, Inc. (MD) Q2 Earnings Cheat Sheet
- Cautious Optimism: Evaluating Pediatrix Medical Group Amid Shifting Birth Trends
- Pediatrix Medical Group Appoints Dr. Kurt Newman to Board